Evaluating the Safety and Efficacy of SGLT-2 Inhibitors on Reducing Cardiovascular and Renal Mortality, Morbidity and Inflammatory Outcomes in Various Patient Populations: A Systematic Review and Meta-Analysis of 92 920 Patients.

Background: The effect of Sodium Glucose Co-Transporter 2 inhibitors on cardiovascular, renal, dyslipidemia, and inflammatory markers has not been analyzed simultaneously. The goal is to determine if SGLT2 inhibitors significantly reduce cardiovascular and renal mortality, and improve these health o...

Full description

Bibliographic Details
Published in:Clinical Medicine Insights: Cardiology pp. 1 - 16
Main Authors: Haider, Syed Hamza, Irfan, Areeka, Sheikh, Samir Mustafa, Larik, Muhammad Omar, Raza, Alishba, Khabir, Yumna
Format: meta analysis research systematic review tables/charts Journal Article
Published: Sage Publications Inc. 6/30/2025
Online Access:View this record in EBSCOhost